CLINICAL_TRIALS trial_result · 2015-07-31

Clinical Trial Update: A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD) [NA]

A placebo-controlled trial evaluating Daliresp (roflumilast) in chronic obstructive pulmonary disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Alabama at Birmingham | Conditions: COPD | NA | Status: COMPLETED | Results posted: 2015-07-31